Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$627K Buy
12,798
+2,753
+27% +$128K 0.02% 279
2025
Q4
$438K Buy
10,045
+939
+10% +$42.9K 0.01% 326
2025
Q3
$410K Buy
9,106
+2,249
+33% +$98.8K 0.01% 339
2025
Q2
$298K Buy
6,857
+1,482
+28% +$66K 0.01% 371
2025
Q1
$248K Buy
+5,375
New +$225K 0.01% 391
2020
Q4
Sell
-1,077
Closed -$29K 272
2020
Q3
$29K Buy
+1,077
New +$28.6K 0.01% 272
2020
Q2
Sell
-1,077
Closed -$27.9K 251
2020
Q1
$27.9K Hold
1,077
0.01% 274
2019
Q4
$35.5K Sell
1,077
-39
-3% -$1.26K 0.01% 326
2019
Q3
$38.1K Buy
+1,116
New +$37.5K 0.01% 277
2019
Q2
Sell
-1,095
Closed -$38.1K 280
2019
Q1
$38.1K Buy
+1,095
New +$37.3K 0.01% 267

Other funds holding EXC

Advisory Alpha's EXC Position: Q1 2026 in Review

Advisory Alpha increased its Exelon (EXC) stake by 27% in Q1 2026, buying an estimated $128K and bringing the position to 12,798 shares worth $627K. The position accounts for 0.02% of the portfolio, ranked #279.

Advisory Alpha first reported a position in EXC in Q1 2019 and has held it in 10 quarters since. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Advisory Alpha held 12,798 shares of Exelon worth $627K as of Q1 2026.
  • Advisory Alpha bought 2,753 Exelon shares in Q1 2026, an estimated $128K.
  • Exelon made up 0.02% of Advisory Alpha's portfolio in Q1 2026, its #279 holding.
  • Advisory Alpha first reported a position in Exelon in Q1 2019 and has held it in 10 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.